ADMA Biologics Inc (ADMA) ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research

ADMA Biologics Inc (NASDAQ: ADMA) FY 2026 Other Release

Newsdesk: